Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.2 USD | +0.34% | -1.20% | +18.47% |
05:02pm | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.47% | 326B | |
+31.56% | 699B | |
+25.10% | 571B | |
-4.15% | 364B | |
+2.83% | 286B | |
+14.53% | 236B | |
+4.57% | 198B | |
-12.19% | 194B | |
-3.87% | 154B | |
-3.67% | 149B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Company's Supplemental Biologics License Application for Vaxneuvance Gets FDA Priority Review